Moberg Pharma AB Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Moberg Pharma AB

Moberg Pharma AB | Mutual Funds

Mutual Funds that own Moberg Pharma AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Grandeur Peak International Opportunities Fund

133,908

0.76%

-200,286

0.08%

04/30/2018

Grandeur Peak Global Opportunities Fund

114,016

0.64%

-141,641

0.08%

04/30/2018

Grandeur Peak Global Reach Fund

111,100

0.63%

0.16%

04/30/2018

SEB Sverige Indexfond

45,670

0.26%

0.01%

12/31/2017

Skandia Sverige Exponering

8,323

0.05%

0.01%

07/31/2018

Catella Sverige Index

3,600

0.02%

0.01%

08/31/2018

Handelsbanken Sverigefond Index

-62,872

08/31/2018

Handelsbanken Sverige Criteria

-18,589

08/31/2018

Strand Småbolagsfond

-125,000

06/30/2017

-20,900

04/30/2018

About Moberg Pharma AB

View Profile

Address	Gustavslundsvägen 42, 5 tr Bromma AB 167 51 Sweden
Employees	-
Website	http://www.mobergpharma.se
Updated	07/08/2019
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. It offers its products through the following brands: Kerasal, Kerasal Nail, Balmex, NewSkin, Dermoplast, Domeboro, and Fiber Choice. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.